Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“The WIN Precision Medicine Symposium by WIN Consortium in cancer personalized medicine was a phenomenal success! Huge kudos to Drs. Wafik S. El-Deiry and Razelle Kurzrock for convening the who’s who of precision oncology.
Such a delight to deliver a lecture and joined Q&A + participate in the lively Molecular Tumor Board sessions.”
More posts featuring Vivek Subbiah.
